STRATEGIC-PLANNING FOR THE MANAGEMENT OF BIOTECHNOLOGIC PRODUCTS - DEVELOPMENT OF A BIOTECH COMMITTEE

Citation
K. Akinwande et al., STRATEGIC-PLANNING FOR THE MANAGEMENT OF BIOTECHNOLOGIC PRODUCTS - DEVELOPMENT OF A BIOTECH COMMITTEE, Hospital formulary, 28(9), 1993, pp. 773
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Hospital formulary
ISSN journal
00986909 → ACNP
Volume
28
Issue
9
Year of publication
1993
Database
ISI
SICI code
Abstract
Strategies and tactics for managing biotechnologic products are critic al to cope with the increasing number and cost of such products. one s trategy is to develop a biotech committee to formulate long-term goals for managing biotechnologic products and to evaluate controversial or extremely expensive new products and recommend their formulary status to the P & T Committee. Involvement of the P & T Committee is crucial to establish strict criteria and monitors to ensure the appropriate a nd cost-effective use of these products. Involvement of the pharmacy d epartment is also essential to detect usage patterns and reimbursement profiles of approved biotechnologic products in the hospital, as well as their potential financial impact on the hospital's budget.